US 7435755
CDDO-compounds and combination therapies thereof
granted A61KA61K31/203A61K31/275
Quick answer
US patent 7435755 (CDDO-compounds and combination therapies thereof) held by The Board of Regents of the University of Texas System expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 51
- CPC classes
- A61K, A61K31/203, A61K31/275, A61K45/06